COMMUNIQUÉS West-GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024
15/07/2024
SAN JOSE, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
15/07/2024
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, August 7, [...]
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
15/07/2024
MARLBOROUGH, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will release financial results for the second quarter of [...]
Abivax Provides Operational and Key Program Update
15/07/2024
Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) on track to complete enrollment in early Q1 2025 Top-line results [...]
Claritas HealthTech Receives Clearance from Indian Regulator CDSCO for Claritas iPET™ Software in India for Improving Quality and Efficiency of PET-CT & PET-MRI Scans
15/07/2024
BENGALURU, India and LONDON, July 15, 2024 (GLOBE NEWSWIRE) -- Claritas HealthTech Ltd (“Claritas”) , a healthcare technology company specializing in advanced medical image enhancement, reconstruction, and AI solutions [...]
Organic growth of 20% of the revenue as of June 24
15/07/2024
Press release Ecully, July 11, 2023 – 6 p.m. First-half 2023 revenue of €5.4 million (+75%) Continued ramp-up of Distimp products Strong sales growth in Europe In thousands of euros Unaudited data 2023 2022 % change [...]
Croissance organiquedu chiffre d'affaires de 20%
15/07/2024
Communiqué de presse Ecully, le 11 juillet 2023 – 18h Chiffre d’affaires du 1 er semestre 2023 de 5,4 M€ (+ 75%) Poursuite de la montée en puissance des produits Distimp Forte progression des ventes en Europe En [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2024
15/07/2024
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2024
15/07/2024
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024
Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024
Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas
15/07/2024
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera BioSolutions, a [...]
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
15/07/2024
Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- Sabin Vaccine Institute launched a [...]
SoldierStrong Marks 15ᵗʰ Anniversary With Focus on New Approaches to Help Veterans Take Their Next Steps Forward
15/07/2024
STAMFORD, Conn., July 15, 2024 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit group committed to donating revolutionary medical technology to improve the lives of injured veterans, marks its 15 th anniversary today with [...]
Third Year in a Row, LifeLabs Named by Forbes as one of Canada's Best Employers for Diversity
15/07/2024
Toronto, July 15, 2024 (GLOBE NEWSWIRE) -- LifeLabs has once again been named one of Canada's Best Employers for Diversity by Forbes. This is the third consecutive year LifeLabs has received this recognition. Forbes and [...]
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15/07/2024
HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]
IR-MED Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers
15/07/2024
DiaSafe ™ , IR-MED’s second product , is being developed to provide safe, real-time optical readings of biomarkers to detect the early presence of diabetic foot ulcers with high accuracy Th e most common cause of [...]
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series
15/07/2024
Live video webcast on Wednesday, July 17 th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
15/07/2024
Five total abstracts presented at ASPN 2024 CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American [...]

Pages